A Better Way Psychiatry & TMS
3200 East Guasti Road, Suite 100, Ontario
United States
1 listed treatment center serving Fontana and the surrounding area.
3200 East Guasti Road, Suite 100, Ontario
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Fontana.
7.1 miles away · Riverside
4361 Latham Street, Suite 220, Riverside
4.5(204 Google reviews)
8.3 miles away · Riverside
3801 University Avenue, Suite 270, Riverside
5.0(12 Google reviews)
8.3 miles away · Riverside
3801 University Avenue, Suite 270, Riverside
4.5(102 Google reviews)
9.2 miles away · San Bernardino
13.6 miles away · Riverside
11801 Pierce Street, Ste 200, Riverside
For people in Fontana, the cost of SPRAVATO® depends on insurance benefits, the treatment setting, and the services billed. The medication and the observed treatment and monitoring visit may generate separate charges. Ask for an estimate that includes both rather than assuming a medication copay covers the whole appointment.
Many plans require prior authorization before treatment begins. The treatment center may need records of earlier antidepressant trials, including which medicines you took and how you responded. Ask which records are needed and whether the center will request them from previous prescribers. Approval is not guaranteed, and ongoing treatment may require additional review.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. California’s Medicaid program may also cover treatment, but coverage and provider participation vary. Confirm benefits directly with your plan and the center; a directory listing does not establish insurance acceptance.
Manufacturer savings programs exist for eligible commercially insured patients. These programs have eligibility restrictions and are not for patients using government insurance such as Medicare or Medicaid. Ask about current requirements without assuming you qualify.
Before scheduling, ask the center and insurer:
SPRAVATO® treatment requires repeated trips to a REMS-certified healthcare setting. You administer the nasal spray yourself under a healthcare provider’s direct observation; it is never sent home with you. Monitoring continues for at least two hours after each dose, so allow additional time for check-in, assessment, and discharge. Your care team decides when you are ready to leave.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance visits may be weekly or every two weeks. Your prescriber individualizes the schedule, so do not assume your appointments will follow a fixed calendar.
Someone else must take you home. You cannot drive or operate machinery until the next day after a restful sleep. Arrange a dependable driver and a backup before starting. If considering a taxi or rideshare, ask the center whether an accompanying adult is required and what discharge arrangements it accepts.
For work and family planning, consider:
If you cannot find an available center in Fontana, expand your search. The supplied directory information includes an Ontario listing that reports offering Spravato, but its REMS certification is unconfirmed. Anaheim, Irvine, and Los Angeles also have listed centers. Confirm certification, availability, insurance participation, and transportation feasibility directly before making plans.
Ask any center you are considering whether the specific treatment location is currently REMS-certified and accepting new patients. The directory information includes an Ontario listing offering Spravato, but its certification status is not confirmed. You can also search listed centers in Anaheim, Irvine, or Los Angeles. A listing alone does not verify certification, availability, or insurance participation.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your diagnosis, treatment history, and medical risks before deciding whether it is appropriate.
Coverage depends on your plan, the treatment setting, and the provider’s participation. Prior authorization and documentation of earlier antidepressant trials are common requirements. Medicare and California Medicaid may cover treatment under certain circumstances, but coverage is not assured. Ask your insurer about both the medication and monitoring services, and confirm your expected share of costs before starting.
You self-administer the nasal spray under direct observation at a REMS-certified healthcare setting. Staff monitor you for at least two hours afterward, including for sedation, dissociation, breathing problems, and blood pressure increases. Discharge depends on your clinical readiness. Arrange someone else to take you home, and do not drive until the next day after a restful sleep.
Discuss sedation, dissociation—feeling disconnected from yourself or your surroundings—breathing problems, and increased blood pressure. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Tell your clinician about your health history, medicines, and substance use so they can assess risks and explain monitoring.
No. If you are in crisis, call or text 988; call 911 for immediate danger or a medical emergency. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior. Even when prescribed for depressive symptoms during an acute suicidal crisis, it does not replace hospitalization when clinically needed. Do not delay emergency care while seeking a treatment appointment.
Approved uses, nearby treatment centers, and medically sourced patient guides.